L-selectin is dispensable for T regulatory cell function postallogeneic bone marrow transplantation

American Journal of Transplantation

Volumn 10, Issue 12, 2010, Pages 2596-2603

  Carlson, M J ^a   Fulton, L M ^a   Coghill, J M ^a   West, M L ^a   Burgents, J E ^a   Wan, Y ^a   Panoskaltsis Mortari, A ^b   Tedder, T F ^c   Blazar, B R ^b   Serody, J S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Allogeneic stem cell transplantation; CD62L; GvHD; regulatory T cells

Indexed keywords

L SELECTIN;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; HISTOPATHOLOGY; IN VITRO STUDY; LYMPH NODE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TARGET ORGAN; WILD TYPE;

ANIMALS; BONE MARROW TRANSPLANTATION; CELL MIGRATION ASSAYS; GRAFT VS HOST DISEASE; L-SELECTIN; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, CHEMOKINE; T-LYMPHOCYTES, REGULATORY;

EID: 78649881395     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03319.x     Document Type: Article

References (20)

1. Appelbaum FR,. Haematopoietic cell transplantation as immunotherapy. Nature 2001; 411: 385-389.
2. Armitage JO,. Bone marrow transplantation. N Engl J Med 1994; 330: 827-838.
3. Ferrara JL, Cooke KR, Pan L, Krenger W,. The immunopathophysiology of acute graft-versus-host-disease. Stem Cells 1996; 14: 473-489.
4. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002; 168: 1080-1086.
5. + T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood 2004; 104: 3804-3812.
6. + regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest 2003; 112: 1688-1696.
7. Kansas GS,. Selectins and their ligands: current concepts and controversies. Blood 1996; 88: 3259-3287.
8. Boyman O, Letourneau S, Krieg C, Sprent J,. Homeostatic proliferation and survival of naive and memory T cells. Eur J Immunol 2009; 39: 2088-2094.
9. + regulatory T cells protects from lethal acute GVHD. Blood 2005; 105: 2220-2226.
10. + regulatory T cells during acute graft-versus-host disease. Blood 2005; 106: 3300-3307.
11. Arbones ML, Ord DC, Ley K, et al,. Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity 1994; 1: 247-260.
12. (+) T cells to the liver, lung, and spleen during graft-versus-host disease. Blood 2000; 96: 2973-2980.
13. Wan YY, Flavell RA,. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci USA 2005; 102: 5126-5131.
14. Coghill JM, Carlson MJ, Panoskaltsis-Mortari A, et al,. Separation of graft-versus-host disease from graft-versus-leukemia responses by targeting CC-chemokine receptor 7 on donor T cells. Blood 2010; 115: 4914-4922.
15. Van Den Brink MR, Moore E, Horndasch KJ, et al,. FAS-deficient LPR mice are more susceptible to graft-versus-host disease. J Immunol 2000; 164: 469-480. (Pubitemid 30013023)
16. Sheng-Tanner X, McKerlie C, Spaner D,. Characterization of graft-versus-host disease in SCID mice and prevention by physicochemical stressors. Transplantation 2000; 70: 1683-1693.
17. + regulatory T cells. J Immunol 2008; 180: 858-869.
18. Krenger W, Hill GR, Ferrara JL,. Cytokine cascades in acute graft-versus-host disease. Transplantation 1997; 64: 553-558. (Pubitemid 27377183)
19. + regulatory T cells. J Exp Med 2004; 199: 303-313.
20. + splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J Immunol 2002; 169: 2461-2465.